Chromatography in Pharmacy & Pharmaceutical

Drug development starts with the discovery of a molecule with a therapeutic value. This can be done by high throughput screening during which separations by fast or ultra-fast HPLC are performed. At the discovery stage there can be also characterizing synthetic or natural products. Drug metabolism and pharmacokinetics (DMPK) is the step where the candidate compounds for drug are tested for their metabolism and pharmacokinetics. The studies involve use of LC-MS or LC-MS/MS. The goal in the discovery stage of drug development is to discover a new, safe and active chemical entity (NCE) that will become medication for diseases. During the last decade parallel synthesis of potential lead compounds, using combinatorial chemistry has been done. Due to its high sensitivity and selectivity, HPLC coupled with tandem mass spectrometry, HPLC-MS/MS has become the predominant method in bioassays, and pharmacokinetic and metabolic studies.

    Related Conference of Chromatography in Pharmacy & Pharmaceutical

    June 25-26, 2024

    13th World Congress on Chromatography

    Toronto, Canada
    August 22-23, 2024

    16th International Conference on Clinical Chemistry

    Berlin, Germany
    October 14-15, 2024

    4th International Conference on Analytical Chemistry

    Barcelona, Spain
    November 13-14, 2024

    5th World Expo on Biopolymers and Bioplastics

    Dubai, UAE
    December 12-13, 2024

    23rd World Congress on Nutrition and Food Chemistry

    Rome, Italy
    December 18-19, 2024

    4th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands

    Chromatography in Pharmacy & Pharmaceutical Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in